HalioDx specializes in the development of innovative diagnostic solutions for cancer immunotherapy. The company focuses on providing advanced tools that enable personalized treatment strategies for patients. Their proprietary technologies are designed to assess the immune response within tumors, which is crucial for predicting patient outcomes and guiding therapeutic decisions. By leveraging a deep understanding of tumor biology and the immune system, HalioDx aims to enhance the precision of cancer treatment and improve patient care.

One of the key technologies employed by HalioDx is the use of immune profiling assays, which analyze the tumor microenvironment to evaluate the presence and activity of immune cells. This approach allows for a comprehensive understanding of how a patient's immune system interacts with their cancer, facilitating the identification of suitable immunotherapies. Additionally, HalioDx's products include diagnostic tests that provide insights into tumor characteristics, helping clinicians make informed decisions regarding treatment options. Overall, HalioDx is committed to advancing cancer diagnostics through innovative technologies that support personalized medicine.

France

HalioDx utilizes a proprietary set of Immune biomarkers, advanced image analysis technologies and a unique know-how to develop, manufacture and commercialize immune-based diagnostics services and products.

HalioDx

Company Details